GW, W., A, H., M, S., JN, B., B, F., SM, V., . . . K, P. (2026). Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of life. International journal of cancer, 159(1), 198. https://doi.org/10.1002/ijc.70396
Chicago Style (17th ed.) CitationGW, Wurschi, et al. "Oxaliplatin-induced Neuropathy After Total Neoadjuvant Therapy for Rectal Cancer: Dose-response Relationship and Impact on Quality of Life." International Journal of Cancer 159, no. 1 (2026): 198. https://doi.org/10.1002/ijc.70396.
MLA (9th ed.) CitationGW, Wurschi, et al. "Oxaliplatin-induced Neuropathy After Total Neoadjuvant Therapy for Rectal Cancer: Dose-response Relationship and Impact on Quality of Life." International Journal of Cancer, vol. 159, no. 1, 2026, p. 198, https://doi.org/10.1002/ijc.70396.